EPC

Over the past six months, Edgewell's stock has been impacted by several events. In November 2025, Edgewell announced the sale of its feminine care business to Essity for $340 million and reported its fourth fiscal quarter 2025 results, with net sales increasing 3.8% (2.5% organic) and a GAAP diluted net loss per share of $(0.66). In February 2026, Edgewell announced its first fiscal quarter 2026 results, reporting a 1.9% increase in net sales, though organic net sales decreased by 0.5%. In March 2026, an analysis suggested that Edgewell might be undervalued. In May 2026, Edgewell reported its second fiscal quarter 2026 results, with net sales increasing 0.6% and adjusted EPS of $0.60, surpassing analyst expectations, however organic net sales declined by 2.4%. The stock also experienced a decline on May 7, 2026, partly due to concerns over rising oil prices impacting input costs for the personal care industry. Hedge fund activity in Q4 2025 and Q1 2026 showed some major institutional investors adding to their positions while others reduced theirs.